These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8290915)

  • 21. Pathologist's role in bladder cancer.
    Farrow GM
    Semin Oncol; 1979 Jun; 6(2):198-206. PubMed ID: 482961
    [No Abstract]   [Full Text] [Related]  

  • 22. The significance of central pathology review in clinical studies of transitional cell carcinoma in situ.
    Sharkey FE; Sarosdy MF
    J Urol; 1997 Jan; 157(1):68-70; discussion 70-1. PubMed ID: 8976218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histological grading of transitional cell tumours of the bladder. Value of histological grading (WHO) in prognosis.
    Collan Y; Mäkinen J; Heikkinen A
    Eur Urol; 1979; 5(5):311-8. PubMed ID: 446506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Urothelial tumors and preneoplasias. Diagnostic problems and their clinical consequences].
    Rogatsch H; Dirnhofer S; Feichtinger H
    Pathologe; 1998 Jan; 19(1):74-84. PubMed ID: 9541946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CLINICO-PATHOLOGICAL PATTERN, CLASSIFICATION AND STAGING OF URINARY BLADDER CARCINOMAS--A FIVE YEARS EXPERIENCE AT A TERTIARY CARE HOSPITAL IN CENTRAL PUNJAB.
    Naeem A; Naseem N; Anwar S; Butt S; Nagi AH
    J Ayub Med Coll Abbottabad; 2015; 27(1):131-4. PubMed ID: 26182758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bladder cancer: improving care with better classification and risk stratification.
    Lamm D
    J Urol; 2007 Oct; 178(4 Pt 1):1146-7. PubMed ID: 17698132
    [No Abstract]   [Full Text] [Related]  

  • 27. Is stage pT4a (D1) reliable in assessing transitional cell carcinoma involvement of the prostate in patients with a concurrent bladder cancer? A necessary distinction for contiguous or noncontiguous involvement.
    Pagano F; Bassi P; Ferrante GL; Piazza N; Abatangelo G; Pappagallo GL; Garbeglio A
    J Urol; 1996 Jan; 155(1):244-7. PubMed ID: 7490845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathology of bladder carcinoma.
    Brodsky GL
    Hematol Oncol Clin North Am; 1992 Feb; 6(1):59-80. PubMed ID: 1556053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Challenges in Pathologic Staging of Bladder Cancer: Proposals for Fresh Approaches of Assessing Pathologic Stage in Light of Recent Studies and Observations Pertaining to Bladder Histoanatomic Variances.
    Paner GP; Montironi R; Amin MB
    Adv Anat Pathol; 2017 May; 24(3):113-127. PubMed ID: 28398951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
    Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
    Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Classification of patients with bladder cancer: clinical versus pathologic staging.
    Cummings KB
    Prog Clin Biol Res; 1984; 162A():33-53. PubMed ID: 6483916
    [No Abstract]   [Full Text] [Related]  

  • 32. [Diagnosis and substaging of pT1 bladder cancer].
    Cheng L; Huang WB; Zheng SQ; Zheng J
    Zhonghua Bing Li Xue Za Zhi; 2007 Sep; 36(9):636-9. PubMed ID: 18070458
    [No Abstract]   [Full Text] [Related]  

  • 33. An assessment of the reliability of the Enneking and Weinstein-Boriani-Biagini classifications for staging of primary spinal tumors by the Spine Oncology Study Group.
    Chan P; Boriani S; Fourney DR; Biagini R; Dekutoski MB; Fehlings MG; Ryken TC; Gokaslan ZL; Vrionis FD; Harrop JS; Schmidt MH; Vialle LR; Gerszten PC; Rhines LD; Ondra SL; Pratt SR; Fisher CG
    Spine (Phila Pa 1976); 2009 Feb; 34(4):384-91. PubMed ID: 19214098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis and staging of bladder cancer.
    Cummings KB; Barone JG; Ward WS
    Urol Clin North Am; 1992 Aug; 19(3):455-65. PubMed ID: 1636230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Automated Detection and Grading of Non-Muscle-Invasive Urothelial Cell Carcinoma of the Bladder.
    Jansen I; Lucas M; Bosschieter J; de Boer OJ; Meijer SL; van Leeuwen TG; Marquering HA; Nieuwenhuijzen JA; de Bruin DM; Savci-Heijink CD
    Am J Pathol; 2020 Jul; 190(7):1483-1490. PubMed ID: 32283104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The muscularis mucosae of the human urinary bladder. Implications for tumor staging on biopsies.
    Engel P; Anagnostaki L; Braendstrup O
    Scand J Urol Nephrol; 1992; 26(3):249-52. PubMed ID: 1439600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The usefulness of the level of the muscularis mucosae in the staging of invasive transitional cell carcinoma of the urinary bladder.
    Younes M; Sussman J; True LD
    Cancer; 1990 Aug; 66(3):543-8. PubMed ID: 2364365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reliability of the routine cytological diagnosis in bladder cancer.
    Páez A; Coba JM; Murillo N; Fernández P; de la Cal MA; Luján M; Berenguer A
    Eur Urol; 1999; 35(3):228-32. PubMed ID: 10072625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carcinoma of the urinary bladder in the Western Cape.
    Tiltman AJ
    S Afr Med J; 1975 Feb; 49(6):176-8. PubMed ID: 1124457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
    Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT
    J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.